Patent details

Basic Information

Publication number:

EP2271321

PCT Application Number:

PCT/GB/2009/050293

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP097263040

PCT Publication Number:

WO/2009/118562

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITION 271

French Title of Invention:

COMPOSITION PHARMACEUTIQUE 271

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNG 271

SPC Number:

Dates

Filing date:

26/03/2009

Grant date:

13/06/2012

EP Publication Date:

13/06/2012

PCT Publication Date:

01/10/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/01/2011

EP B1 Publication Date:

13/06/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

26/03/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/03/2009

 

 

Name:

Array BioPharma Inc.

Address:

3200 Walnut Street, Boulder, CO 80301, United States (US)

Name:

AstraZeneca AB

Address:

-, 151 85 Södertälje, Sweden (SE)

Agent

Name:

ARONOVA S.A.

From:

31/07/2012

Address:

PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)

To:

Inventor

1

Name:

HILL Kathryn, Jane

Address:

United Kingdom (GB)

2

Name:

GELLERT Paul, Richard

Address:

United Kingdom (GB)

3

Name:

BATEMAN Nicola, Frances

Address:

United Kingdom (GB)

Priority

Priority Number:

40372

Priority Date:

28/03/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/48;

Annual Fees

Annual Fee Due Date:

31/03/2026

Annual Fee Number:

18

Annual Fee Amount:

262 Euro

Expected Payer:

Last Annual Fee Payment Date:

18/02/2025

Last Annual Fee Paid Number:

17

Last Annual Fee Paid Amount:

246 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages